Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: IntronA
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
IntronA 10million unit inj vials
0802040J0BBACAH
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 18million units/1.2ml inj multidose pens
0802040J0BBAIBB
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 1million unit inj vials
0802040J0BBAEAK
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 25million units/2.5ml inj multidose vials
0802040J0BBALBE
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 30million units/1.2ml inj multidose pens
0802040J0BBAJBC
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 3million unit inj vials
0802040J0BBAAAG
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 60million units/1.2ml inj multidose pens
0802040J0BBAKBD
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.